FDA.reportPublic FDA data

risedronate sodium 35 MG Oral Tablet

RxCUI
905024
RxNorm name
risedronate sodium 35 MG Oral Tablet
Display name
risedronate sodium 35 MG Oral Tablet
Full name
risedronate sodium 35 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 9 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Risedronate SodiumRISEDRONATE SODIUMTeva Pharmaceuticals USA, Inc.dddcd321-4d2e-4643-bf3c-7b752b33ba392026-03-30Warnings, Adverse reactionsExact identifier
rxcui: 905024
Risedronate SodiumRISEDRONATE SODIUMApotex Corp.b90f2e5b-10b8-29a7-0360-31bd0dae0ec22026-03-02Warnings, Adverse reactionsExact identifier
rxcui: 905024
Risedronate SodiumRISEDRONATE SODIUMMacleods Pharmaceuticals Limited62aff8d6-a2f7-4c7e-a102-c70105ac37922026-03-01Warnings, Adverse reactionsExact identifier
rxcui: 905024
risedronate sodiumRISEDRONATE SODIUMSun Pharmaceutical Industries, Inc.e0b5f0ed-ff40-4f0d-bb86-81a7ace9f3392026-02-17Warnings, Adverse reactionsExact identifier
rxcui: 905024
Risedronate SodiumRISEDRONATE SODIUMMylan Pharmaceuticals, Inc.f715718a-407d-4e2a-9834-74a8f1361d032026-02-12Warnings, Adverse reactionsExact identifier
rxcui: 905024
Risedronate SodiumRISEDRONATE SODIUMAurobindo Pharma Limited89896dfe-f69d-4cb3-bb71-7a7c611071fa2026-02-11Warnings, Adverse reactionsExact identifier
rxcui: 905024
ActonelRISEDRONATE SODIUMAllergan, Inc.24ed00e0-25e2-49a8-97fc-66c1b417dc0b2026-02-04Warnings, Adverse reactionsExact identifier
rxcui: 905024
Risedronate SodiumRISEDRONATE SODIUMHangzhou Minsheng Binjiang Pharmaceutical CO., Ltdd60a56cb-ef49-4447-9043-7b6879a20d752025-12-16Warnings, Adverse reactionsExact identifier
rxcui: 905024
Risedronate SodiumRISEDRONATE SODIUMProficient Rx LP81702f21-3117-49ce-8e9b-2aa2648ba7c32022-11-01Warnings, Adverse reactionsExact identifier
rxcui: 905024

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 10 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
24ed00e0-25e2-49a8-97fc-66c1b417dc0brisedronate sodium 35 MG Oral Tablet [PSN] · risedronate sodium 35 MG Oral Tablet [SCD]231These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® ( risedronate sodium ) tablets , for oral use Initial U.S. Approval: 199 820260204
e0b5f0ed-ff40-4f0d-bb86-81a7ace9f339risedronate sodium 35 MG Oral Tablet [PSN] · risedronate sodium 35 MG Oral Tablet [SCD]217These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820260217
dddcd321-4d2e-4643-bf3c-7b752b33ba39risedronate sodium 35 MG Oral Tablet [PSN] · risedronate sodium 35 MG Oral Tablet [SCD]215These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for RISEDRONATE SODIUM TABLETS . RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820260330
b90f2e5b-10b8-29a7-0360-31bd0dae0ec2risedronate sodium 35 MG Oral Tablet [PSN] · risedronate sodium 35 MG Oral Tablet [SCD]215These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS, USP safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS, USP. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820260302
d60a56cb-ef49-4447-9043-7b6879a20d75risedronate sodium 35 MG Oral Tablet [PSN] · risedronate sodium 35 MG Oral Tablet [SCD]215These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820251216
f715718a-407d-4e2a-9834-74a8f1361d03risedronate sodium 35 MG Oral Tablet [PSN] · risedronate sodium 35 MG Oral Tablet [SCD]213These highlights do not include all the information needed to use Risedronate Sodium safely and effectively. See full prescribing information for Risedronate Sodium . Risedronate Sodium tablets , for oral use Initial U.S. Approval: 199820260212
62aff8d6-a2f7-4c7e-a102-c70105ac3792risedronate sodium 35 MG Oral Tablet [PSN] · risedronate sodium 35 MG Oral Tablet [SCD]29These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, USP, for oral use Initial U.S. Approval: 199820260301
89896dfe-f69d-4cb3-bb71-7a7c611071farisedronate sodium 35 MG Oral Tablet [PSN] · risedronate sodium 35 MG Oral Tablet [SCD]29These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820260211
4423d70a-b120-4653-bcf3-0c5ea8b97b0erisedronate sodium 35 MG Oral Tablet [PSN] · risedronate sodium 35 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® (risedronate sodium) tablets Initial U.S. Approval: 199820100324
81702f21-3117-49ce-8e9b-2aa2648ba7c3risedronate sodium 35 MG Oral Tablet [PSN] · risedronate sodium 35 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS, USP safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS, USP. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820221101